February 2014 FDA Recall Drug by Gilead Sciences, Inc.
D-1090-2014 - Presence of Foreign Substance

This Class III drug recall was voluntarily initiated by Gilead Sciences, Inc. on February 19, 2014 for the product Drug. The FDA reported the reason for recall as presence of foreign substance. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1090-2014

Reason for Recall
Presence of Foreign Substance: Red Silicone Rubber Particulates are Present in Drug.
Initiated
02-19-2014
Reported
03-05-2014
Quantity
39,223 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Gilead Sciences, Inc.
Nationwide including Puerto Rico.
Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) Tablets, 30 Tablet Bottles, Rx only. Manufactured for: Bristol-Myers Squibb & Gilead Sciences, LLC, Foster City, CA 94404. Made in Ireland. NDC 15584-0101-1. Manufactured for: Bristol-Myers-Squibb & Gilead Sciences, LLC, Foster City, CA 94404 Made in Ireland

Batch or Lot Expiration Information

Lot# 's: 002390, 002400, Exp 02/17.